Literature DB >> 33390814

Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.

Rusidanmu Aizemaiti1, Zhigang Wu2, Jie Tang1, Haimeng Yan3, Xiayi Lv1.   

Abstract

Lung adenocarcinoma (LUAD) is the predominant subtype of lung cancer with a relatively poor prognosis. The dramatic improvements of new immunotherapy strategies have shown promising results in lung cancer patients. This study aimed to elucidate the functions of immune-associated genes in LUAD prognosis and pathogenesis by analyzing public databases. We obtained expression profiles of LUAD patients from The Cancer Genome Atlas (TCGA) database and applied the ESTIMATE algorithm to calculate immune scores and stromal scores. A series of microenvironment-related genes with prognostic value was then identified. Of note, heat shock factor 5 (HSF5) was found to be decreased in LUAD patients and positively correlated with overall survival, which was further confirmed in the Gene Expression Omnibus (GEO) database. Moreover, Gene Ontology (GO) analysis based on the correlated genes of HSF5 demonstrated that HSF5 expression was significantly associated with the immune response and inflammatory activities. Based on the Tumor IMmune Estimation Resource (TIMER) and Gene Expression Profiling Interactive Analysis (GEPIA) datasets, HSF5 expression showed strong correlations with various immune cell infiltration and diverse immune marker sets. These findings suggest that HSF5 can be used as a promising biomarker for determining prognosis and immune infiltration in LUAD patients. © The author(s).

Entities:  

Keywords:  HSF5; immune infiltration; inflammatory activities; lung adenocarcinoma; prognostic biomarker

Mesh:

Substances:

Year:  2021        PMID: 33390814      PMCID: PMC7757139          DOI: 10.7150/ijms.51297

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  42 in total

1.  Heat Shock Factor 5 Is Essential for Spermatogenesis in Zebrafish.

Authors:  Jolly M Saju; Mohammad Sorowar Hossain; Woei Chang Liew; Ajay Pradhan; Natascha May Thevasagayam; Lydia Shun En Tan; Amit Anand; Per-Erik Olsson; László Orbán
Journal:  Cell Rep       Date:  2018-12-18       Impact factor: 9.423

2.  Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.

Authors:  Yonit Lavin; Soma Kobayashi; Andrew Leader; El-Ad David Amir; Naama Elefant; Camille Bigenwald; Romain Remark; Robert Sweeney; Christian D Becker; Jacob H Levine; Klaus Meinhof; Andrew Chow; Seunghee Kim-Shulze; Andrea Wolf; Chiara Medaglia; Hanjie Li; Julie A Rytlewski; Ryan O Emerson; Alexander Solovyov; Benjamin D Greenbaum; Catherine Sanders; Marissa Vignali; Mary Beth Beasley; Raja Flores; Sacha Gnjatic; Dana Pe'er; Adeeb Rahman; Ido Amit; Miriam Merad
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

3.  A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma.

Authors:  Shanbo Zheng; Xiaoyang Luo; Chuanpeng Dong; Difan Zheng; Juntao Xie; Lingdun Zhuge; Yihua Sun; Haiquan Chen
Journal:  Int J Cancer       Date:  2018-09-17       Impact factor: 7.396

4.  Global human tissue profiling and protein network analysis reveals distinct levels of transcriptional germline-specificity and identifies target genes for male infertility.

Authors:  Frédéric Chalmel; Aurélie Lardenois; Bertrand Evrard; Romain Mathieu; Caroline Feig; Philippe Demougin; Alexandre Gattiker; Wolfgang Schulze; Bernard Jégou; Christiane Kirchhoff; Michael Primig
Journal:  Hum Reprod       Date:  2012-08-27       Impact factor: 6.918

Review 5.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

6.  Objective measurement and clinical significance of TILs in non-small cell lung cancer.

Authors:  Kurt A Schalper; Jason Brown; Daniel Carvajal-Hausdorf; Joseph McLaughlin; Vamsidhar Velcheti; Konstantinos N Syrigos; Roy S Herbst; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2015-02-03       Impact factor: 11.816

7.  Heat-shock factor 2 is a suppressor of prostate cancer invasion.

Authors:  J K Björk; M Åkerfelt; J Joutsen; M C Puustinen; F Cheng; L Sistonen; M Nees
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

8.  Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.

Authors:  M Henar Alonso; Susanna Aussó; Adriana Lopez-Doriga; David Cordero; Elisabet Guinó; Xavier Solé; Mercè Barenys; Javier de Oca; Gabriel Capella; Ramón Salazar; Rebeca Sanz-Pamplona; Victor Moreno
Journal:  Br J Cancer       Date:  2017-07-06       Impact factor: 7.640

9.  Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease.

Authors:  Rocio Gomez-Pastor; Eileen T Burchfiel; Daniel W Neef; Alex M Jaeger; Elisa Cabiscol; Spencer U McKinstry; Argenia Doss; Alejandro Aballay; Donald C Lo; Sergey S Akimov; Christopher A Ross; Cagla Eroglu; Dennis J Thiele
Journal:  Nat Commun       Date:  2017-02-13       Impact factor: 14.919

10.  T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

Authors:  Achim Rody; Uwe Holtrich; Laos Pusztai; Cornelia Liedtke; Regine Gaetje; Eugen Ruckhaeberle; Christine Solbach; Lars Hanker; Andre Ahr; Dirk Metzler; Knut Engels; Thomas Karn; Manfred Kaufmann
Journal:  Breast Cancer Res       Date:  2009-03-09       Impact factor: 6.466

View more
  2 in total

Review 1.  More Than Meets the Eye: Revisiting the Roles of Heat Shock Factor 4 in Health and Diseases.

Authors:  Saiful Effendi Syafruddin; Sheen Ling; Teck Yew Low; M Aiman Mohtar
Journal:  Biomolecules       Date:  2021-03-31

2.  Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.

Authors:  Bo Yang; Lin-Lin Ji; Hong-Liang Xu; Xiao-Ping Li; Hong-Gang Zhou; Ting Xiao; Xiao-He Li; Zhou-Yong Gao; Jian-Zhong Li; Wei-Dong Zhang; Guang-Shun Wang; Ming-Jiang Li
Journal:  J Inflamm Res       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.